One Tracer, Whole Syndrome: CAIX-Targeted PET Unmasks the Multisystem Tumor Landscape of Von Hippel-Lindau Disease.

Clin Nucl MedSep 24, 2026 (epub)

Esra Arslan, Halil Kömek, Canan Can et al.

✦ AI-curated · Sources linked

Case in brief

A 50-year-old man with von Hippel–Lindau disease underwent multimodal imaging to assess residual central nervous system disease. ⁶⁸Ga-DOTATATE PET/CT showed one cerebellar lesion, and ¹⁸F-FDG PET/CT was negative despite active disease. In contrast, [⁶⁸Ga]Ga-DPI-4452 PET/CT, targeting carbonic anhydrase IX (CAIX), depicted cerebellar and spinal hemangioblastomas, recurrent and contralateral clear cell renal cell carcinoma lesions, and epididymal involvement. The report illustrates how CAIX-targeted imaging revealed multisystem tumor burden not shown by the other PET studies.

What made this case unusual

CAIX-targeted PET/CT depicted widespread VHL-associated lesions despite negative ¹⁸F-FDG PET/CT and a single lesion on ⁶⁸Ga-DOTATATE PET/CT.

Diagnostic / clinical pearl

In this patient with VHL, CAIX-targeted PET/CT visualized multisystem disease that was not apparent on ¹⁸F-FDG PET/CT; imaging choice can affect the apparent extent of tumor burden.

Source

Published in Clin Nucl Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Medical Genetics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.